Immune response with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Phase II ProACT study

被引：0
|
作者：
Gardner, Thomas A.
Petrylak, Daniel Peter
Corman, John M.
Hall, Simon
Weinstein, Ralph
Keyser, Robert
Sims, Robert Brownell
Sanders, Amanda
Sheikh, Nadeem A.
Higano, Celestia S.
机构：
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] US Oncol, Portland, OR USA
[6] Dendreon Corp, Seattle, WA USA
[7] Univ Washington, Sch Med, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
148
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
    Mulders, Peter F.
    De Santis, Maria
    Powles, Thomas
    Fizazi, Karim
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (06) : 655 - 663
  • [12] Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer
    Crawford, E. David
    Petrylak, Daniel P.
    Higano, Celestia S.
    Kibel, Adam S.
    Kantoff, Philip W.
    Small, Eric J.
    Shore, Neal D.
    Ferrari, Anna
    CANADIAN JOURNAL OF UROLOGY, 2015, 22 (06) : 8048 - 8055
  • [13] Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED
    Nabhan, Chadi
    Sartor, A. Oliver
    Cooperberg, Matthew R.
    Armstrong, Andrew J.
    Vacirca, Jeffrey L.
    Concepcion, Raoul S.
    Berry, William R.
    Dhawan, Manish
    Tutrone, Ronald
    Sandler, Andrew
    McCoy, Candice
    Whitmore, James Boyd
    Tyler, Robert Claude
    Higano, Celestia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [14] Sipuleucel-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients >= 80 Years-Old: Data From PROCEED
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (04) : 11 - 11
  • [15] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer REPLY
    Kantoff, Philip W.
    Frohlich, Mark W.
    Schellhammer, Paul F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1967 - 1968
  • [16] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
    Kantoff, Philip W.
    Higano, Celestia S.
    Shore, Neal D.
    Berger, E. Roy
    Small, Eric J.
    Penson, David F.
    Redfern, Charles H.
    Ferrari, Anna C.
    Dreicer, Robert
    Sims, Robert B.
    Xu, Yi
    Frohlich, Mark W.
    Schellhammer, Paul F.
    Ahmed, T.
    Amin, A.
    Arseneau, J.
    Barth, N.
    Bernstein, G.
    Bracken, B.
    Burch, P.
    Caggiano, V.
    Chin, J.
    Chodak, G.
    Chu, F.
    Corman, J.
    Curti, B.
    Dawson, N.
    Deeken, J. F.
    Dubernet, T.
    Fishman, M.
    Flanigan, R.
    Gailani, F.
    Garbo, L.
    Gardner, T.
    Gelmann, E.
    George, D.
    Godfrey, T.
    Gomella, L.
    Guerra, M.
    Hall, S.
    Hanson, J.
    Israeli, R.
    Jancis, E.
    Jewett, M. A. S.
    Kassabian, V.
    Katz, J.
    Klotz, L.
    Koeneman, K.
    Koh, H.
    Kratzke, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05): : 411 - 422
  • [17] Sipuleucel-T in Metastatic Castration-Resistant Prostate Concert Profile Report
    Plosker, Greg L.
    BIODRUGS, 2011, 25 (04) : 255 - 256
  • [18] Real-world experience with sipuleucel-T in patients (pts) ≥80 years old with metastatic castration-resistant prostate cancer (mCRPC): Data from PROCEED
    Nabhan, Chadi
    Sartor, A. Oliver
    Cooperberg, Matthew R.
    Vacirca, Jeffrey L.
    Concepcion, Raoul S.
    Berry, William R.
    Dhawan, Manish
    Tutrone, Ronald
    Sandler, Andrew
    Mccoy, Candice
    Whitmore, James Boyd
    Tyler, Robert Claude
    Higano, Celestia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [19] Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
    Sinha, Meenal
    Zhang, Li
    Subudhi, Sumit
    Chen, Brandon
    Marquez, Jaqueline
    Liu, Eric V.
    Allaire, Kate
    Cheung, Alexander
    Ng, Sharon
    Nguyen, Christopher
    Friedlander, Terence W.
    Aggarwal, Rahul
    Spitzer, Matthew
    Allison, James P.
    Small, Eric J.
    Sharma, Padmanee
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [20] A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Danila, Daniel Costin
    Waterhouse, David Michael
    Appleman, Leonard Joseph
    Pook, David William
    Matsubara, Nobuaki
    Dorff, Tanya B.
    Lee, Jae-Lyun
    Armstrong, Andrew J.
    Kim, Miso
    Horvath, Lisa
    Sumey, Christopher Joseph
    Cooner, Freda
    Salvati, Mark
    Stieglmaier, Julia
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345